BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2882282)

  • 1. Subcutaneous infusion of apomorphine and lisuride in the treatment of parkinsonian on-off fluctuations.
    Stibe C; Lees A; Stern G
    Lancet; 1987 Apr; 1(8537):871. PubMed ID: 2882282
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease.
    Vaamonde J; Luquin MR; Obeso JA
    Mov Disord; 1990; 5(3):260-2. PubMed ID: 2388647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous lisuride infusion in Parkinson's disease: clinical results using different modes of administration.
    Stocchi F; Ruggieri S; Antonini A; Baronti F; Brughitta G; Bellantuono P; Bravi D; Agnoli A
    J Neural Transm Suppl; 1988; 27():27-33. PubMed ID: 3165437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of lisuride after subcutaneous infusion.
    Krause W; Nieuweboer B; Ruggieri S; Stocchi F; Suchy I
    J Neural Transm Suppl; 1988; 27():71-4. PubMed ID: 3165439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One year treatment with lisuride delivery pump in Parkinson's disease.
    Ruggieri S; Stocchi F; Carta A; Bragoni M; Agostini C; Barbato L; Agnoli A
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):173-83. PubMed ID: 2748858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous subcutaneous lisuride infusions in Parkinson's disease.
    Critchley PH; Grandas Perez F; Quinn NP; Parkes JD; Marsden CD
    J Neural Transm Suppl; 1988; 27():55-60. PubMed ID: 2969953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous dopaminergic stimulation in Parkinson disease].
    Obeso JA; Luquin MR; Vaamonde J; Grandas F; Pastor MA; Artieda J; Martínez-Lage JM
    Neurologia; 1987; 2(5):227-34. PubMed ID: 2908545
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Parkinson's disease with subcutaneous lisuride infusions.
    Fernandez Pardal M; Micheli F; Gatto M; Perez y Gonzalez N
    J Neural Transm Suppl; 1988; 27():75-84. PubMed ID: 2969954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease.
    Obeso JA; Luquin MR; Martínez-Lage JM
    Lancet; 1986 Mar; 1(8479):467-70. PubMed ID: 2869209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic s.c. lisuride in Parkinson's disease--motor-performance and avoidance of psychiatric side effects.
    Bittkau S; Przuntek H
    J Neural Transm Suppl; 1988; 27():35-54. PubMed ID: 3165438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous apomorphine in parkinsonian on-off oscillations.
    Stibe CM; Lees AJ; Kempster PA; Stern GM
    Lancet; 1988 Feb; 1(8582):403-6. PubMed ID: 2893200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisuride combined with levodopa in advanced Parkinson disease.
    Lieberman AN; Goldstein M; Leibowitz M; Neophytides A; Gopinathan G; Walker R; Pact V
    Neurology; 1981 Nov; 31(11):1466-9. PubMed ID: 7031504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic subcutaneous minipump infusion of lisuride upon locomotor activity of rats.
    Wachtel H; Rettig KJ; Löschmann PA
    J Neural Transm Suppl; 1988; 27():177-83. PubMed ID: 3165433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine and lisuride infusion. A comparative chronic study.
    Stocchi F; Bramante L; Monge A; Viselli F; Baronti F; Stefano E; Ruggieri S
    Adv Neurol; 1993; 60():653-5. PubMed ID: 8420205
    [No Abstract]   [Full Text] [Related]  

  • 15. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 May; 1(8490):1150-1. PubMed ID: 2871399
    [No Abstract]   [Full Text] [Related]  

  • 16. [Orally administered lisuride in the treatment of complex fluctuations of motion in Parkinson disease].
    Luquín MR; Obeso JA; Vaamonde J; Martínez Lage JM
    Neurologia; 1989 Sep; 4(7):229-32. PubMed ID: 2638588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between L-dopa and lisuride intravenous infusions: a clinical study.
    Ruggieri S; Stocchi F; Carta A; Bravi D; Bragoni M; Giorgi L; Agnoli A
    Mov Disord; 1988; 3(4):313-9. PubMed ID: 3211176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisuride infusion pump in Parkinson's disease. A report of two cases.
    Gershanik OS; Scipioni O; García S
    J Neural Transm Suppl; 1988; 27():85-90. PubMed ID: 2969955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lisuride infusion pump for Parkinson's disease.
    Lancet; 1986 Aug; 2(8502):348-9. PubMed ID: 2874360
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of lisuride in the "on-off" phenomena due to L-dopa].
    Piccinin GL; Piccirilli M; Rizzo PA; Agostini L
    Clin Ter; 1983 Mar; 104(6):469-71. PubMed ID: 6851447
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.